Establishment Labs Holdings, Inc. (ESTA)
72.39
+0.33
(+0.46%)
USD |
NASDAQ |
Aug 25, 14:57
Establishment Labs Holdings EPS Diluted (Quarterly) : -0.39 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.39 |
| March 31, 2026 | -0.4468 |
| December 31, 2025 | -0.0878 |
| September 30, 2025 | -0.3763 |
| June 30, 2025 | -0.5739 |
| March 31, 2025 | -0.7026 |
| December 31, 2024 | -1.193 |
| September 30, 2024 | -0.5905 |
| June 30, 2024 | -0.6157 |
| March 31, 2024 | -0.5831 |
| December 31, 2023 | -0.7882 |
| September 30, 2023 | -1.124 |
| June 30, 2023 | -0.6537 |
| March 31, 2023 | -0.4839 |
| December 31, 2022 | -0.5556 |
| September 30, 2022 | -0.7591 |
| June 30, 2022 | -1.521 |
| March 31, 2022 | -0.2441 |
| December 31, 2021 | -0.5893 |
| September 30, 2021 | -0.6093 |
| June 30, 2021 | -0.2222 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.2916 |
| December 31, 2020 | -0.24 |
| September 30, 2020 | -0.1799 |
| June 30, 2020 | -0.4459 |
| March 31, 2020 | -0.7906 |
| December 31, 2019 | -0.2691 |
| September 30, 2019 | -0.6195 |
| June 30, 2019 | -0.4421 |
| March 31, 2019 | -0.5259 |
| December 31, 2018 | -0.5183 |
| September 30, 2018 | 0.0649 |
| June 30, 2018 | -0.2618 |
| March 31, 2018 | -0.3429 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -0.4707 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.75M |
| Revenue (Quarterly) | 67.54M |
| Total Expenses (Quarterly) | 79.29M |
| Enterprise Value | 2.339B |
| Gross Profit Margin (Quarterly) | 70.64% |
| Profit Margin (Quarterly) | -17.39% |
| Earnings Yield | -1.80% |
| Normalized Earnings Yield | -1.797 |